HealthDay News — A once-promising investigational vaccine against herpes viruses showed only 20% efficacy against herpes genital disease in a large clinical trial designed to mimic the general ...

Around one in every five people aged below 50 around the world is infected with incurable genital herpes, researchers have newly estimated. According to a new paper in the journal Sexually Transmitted ...

Herpes simplex virus is a master of bad timing—reappearing briefly, often unnoticed, and just long enough to keep the immune system on its toes. In its genital form, herpes simplex virus type 2 (HSV-2 ...

Genital herpes infections are very common. There are 42 million new infections each year — that averages out to one new person infected each second. While treatments can help with symptoms, there's no ...

The present study provides an update on previous estimates of the global and regional incidence (new cases) and prevalence (existing ones) of HSV-1 and HSV-2 in 2012 and 2016. In addition to estimates ...

March 25, 2003 (San Francisco) — Final analysis of a multicenter study of 1,484 herpes simplex virus 2 (HSV-2)–discordant couples indicates that chronic valacyclovir suppressive therapy can reduce the ...

Assembly Biosciences is advancing its herpes drug to Phase II trials after it showed 94% antiviral efficacy in a Phase Ib trial. In the study (NCT06385327), ABI-5366, an investigational long-acting ...

HSV-1 usually causes oral herpes, while HSV-2 primarily affects the genitals. You may not know you have herpes because it ...

HSV-2 causes genital herpes, and neurological complications include aseptic meningitis and recurrent radiculopathy. HSV-2 also causes myelitis in immunocompromised individuals. Typical features of HSV ...